<DOC>
	<DOCNO>NCT00725829</DOCNO>
	<brief_summary>The aim current study evaluate whether treatment high dos simvastatin reduce coagulation activation patient acute coronary syndrome ezetimibe conjunction simvastatin may affect blood clot similar manner . The investigator hypotheses follow : 1 . Intensive lipid lower treatment simvastatin ( 40 mg/day ) simvastatin ( 40 mg/day ) combine ezetimibe ( 10 mg/day ) initiate acute coronary syndrome lead attenuation blood coagulation include reduce thrombin generation , thrombin-mediated coagulant reaction , improved structure plasma clot . 2 . Anticoagulant effect simvastatin weak observed administration simvastatin ezetimibe .</brief_summary>
	<brief_title>Hypolipemic Treatment Acute Coronary Syndrome ( ACS ) : Antithrombotic Effects</brief_title>
	<detailed_description>Clinical status evaluate hospitalization , out-patient basis . All cardiovascular event ( fatal nonfatal myocardial infarction , unstable angina , sudden cardiac death , all-cause death , stroke , TIA ) record patient underwent acute PCI follow-up coronary angiography perform accord current recommendation . However , clinical analysis major gaol study . The investigator plan evaluate follow parameter : - Whole blood morphology , creatinine , glucose , sodium , potassium , urea , lipid profile , CK , AST , fibrinogen , use standard method hospital laboratory . - Inflammation marker - fibrinogen ( nephelometry , Dade Behring ) high-sensitivity C-reactive protein ( nephelometry , Dade Behring ) ; interleukin 6 ( ELISA , R &amp; D Systems ) . - Thrombin generation marker peripheral blood - thrombin-antithrombin complex [ TAT ] ( ELISA , Dade Behring ) ; prothrombin fragment 1+2 [ F1+2 ] ( ELISA , Dade Behring ) . - Fibrin clot permeation susceptibility lysis - measurement Darcy 's constant ( dimension pore structure clot ) measurement volume buffer ( 0,05 mol/l Tris HCl 0,15 mol/l NaCl ) penetrate fibrin gel make polystyrene pipe , 1.3 mm diameter , 100 ul citrate plasma addition 1U/ml human thrombin 20 mmol/l calcium chloride room temperature within 120 minute accord methodology describe Mills al . - Fibrin gel turbidimetry - plasma mixed Tris buffer prepare mention 2:3 ratio , addition 1 U/ml thrombin 16 mmol/l calcium chloride analyze UV spectrometer ( wave length 405 nm ) . Following variable measure : initiation time , absorption increase time absorption value plateau , approximately 10 minute addition thrombin mixture . After 2 hour , spectrophotometry assessment clot perform ( 400 800 nm ) measure pore size thickness fibrin fiber use Carr equation modify Wolberg . Then fibrinolysis fibrin gel measure mean turbidimetry . Another lysis assay base measurement D-dimer level effluent flow fibrin gel perform accord method Collet et al . - Activation coagulation system `` minimally modify blood '' model accord Rand et al . Non-anticoagulated blood divide 10 1-ml sample add tubes TF phospholipid , clot stop anticoagulant cocktail . In supernatant sample , Western blot HPLC analysis fibrinopeptide perform described previously . In 40 patient allocated random ass activation coagulation system use vascular injury model accord procedure develop u . We measure : - Activation prothrombin - Conversion fibrinogen fibrin - Activation factor V inactivation factor Va - Activation factor XIII - Activation TAFI - Thrombin generation Genetic analysis The investigator determine PlA1 PlA2 polymorphism integrin Î²3 gene use PCR technique DNA sample collect peripheral blood leukocyte . Additionally , go search polymorphism promoter region IL-6 /G-174C also mean PCR DNA collect peripheral blood leukocyte , use prim-ers 5'- AAT CTT TGT TGG AGG GTG AG 5'- ACA TGC CAA GTG CTG AGT CA restriction endonuclease Sfa NI 2 % agarose gel .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Age &lt; 75 year Acute coronary syndrome ( symptom onset &lt; 12 h ) Diabetes insulin Anticoagulant therapy Renal insufficiency Liver injury Acute cardiovascular event within previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>coagulation</keyword>
	<keyword>cholesterol</keyword>
	<keyword>acute ischemia</keyword>
	<keyword>fibrin clot</keyword>
</DOC>